Related Experiment Videos
Insights
Coronary artery bypass grafting (CABG) increases survival for patients with severe ischemic heart disease, reducing fatal heart attacks. Treatment outcomes are similar across age groups but influenced by other health conditions.
Area of Science:
- Cardiology
- Cardiac Surgery
- Clinical Trials
Background:
- Ischemic heart disease poses significant survival challenges.
- Medical and surgical interventions are key management strategies.
- Large-scale trials are crucial for evaluating treatment efficacy.
Purpose of the Study:
- To evaluate the long-term effects of medical versus surgical management for ischemic heart disease.
- To assess the impact of coronary artery bypass grafting (CABG) on survival and secondary endpoints.
- To analyze treatment outcomes in specific patient subgroups, including those with left ventricular dysfunction and the elderly.
Main Methods:
- Analysis of data from three large cooperative randomized trials.
- Comparison of survival rates and secondary endpoints between medical management and CABG.
- Stratification of results based on disease severity (e.g., left main stenosis, triple-vessel disease) and left ventricular function.
Main Results:
- CABG significantly increases survival in patients with left main coronary artery stenosis, triple-vessel disease, double-vessel disease, left ventricular functional impairment, or left ventricular aneurysm.
- CABG reduces the incidence of fatal myocardial infarction but not nonfatal events.
- Outcomes in patients aged 65 and older are comparable to younger patients, though influenced by comorbidities.
- Gainful employment and risk factors remain unaffected by treatment.
- CABG alone did not improve congestive heart failure symptoms; LV aneurysmectomy did.
Conclusions:
- CABG offers survival benefits for specific patient populations with ischemic heart disease.
- The procedure effectively reduces fatal myocardial infarction incidence.
- Surgical intervention, particularly LV aneurysmectomy, can address specific complications like heart failure symptoms.
Abstract:
Three large cooperative randomized trials have evaluated the effects of medical and surgical management of ischemic heart disease on survival and other secondary end points. Both randomized and observational data from these trials show increased survival following coronary artery bypass grafting (CABG) in patients with left main coronary artery stenosis, triple-vessel disease, double-vessel disease, left ventricular (LV) functional impairment, or LV aneurysm. The incidence of fatal, but not nonfatal, myocardial infarction is reduced by CABG. Results in patients 65 years of age or older are similar to those in younger patients but are influenced by associated disease. Gainful employment and risk factors are uninfluenced by treatment. Symptoms of congestive heart failure were not improved by CABG alone but were improved by LV aneurysmectomy when this was performed.